Most Popular

UK: CellCentric raises US$220m in oversubscribed Series D financing

CellCentric, a clinical-stage biotechnology company, has completed an oversubscribed US$220m Series D financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management & Research Company, Sofinnova Partners and HBM Healthcare, alongside existing investors RA Capital Management, Forbion, Pfizer, Avego BioScience Capital and American Cancer Society BrightEdge. Proceeds will support...

Germany: Fresenius invests in Avelios Medical and further expands its strategic partnership with SAP

Fresenius, a global, therapy-focused healthcare company, together with SAP, is investing in Avelios Medical, a Munich-based company developing a next-generation, cloud-native hospital information system. The deal builds on the partnership between Fresenius and SAP. In January this year, the companies announced plans to accelerate innovation for stronger digital healthcare delivery, with the intention of creating a digital backbone for a sovereign, interoperable, and AI-supported healthcare system. The idea is to provide an open, integrated, and data‑driven digital health ecosystem that enables hospitals and medical facilities worldwide to use AI securely...